BioCentury
ARTICLE | Clinical News

Allon preclinical data

February 7, 2011 8:00 AM UTC

In a mouse model of PD, intranasal davunetide for 2 months significantly improved motor performance and coordination by 38% vs. vehicle-treated controls (p<0.01). Data were published in Molecular and ...